Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
CO-PRESENTED BY
LIVE TV DownloadNews18 App
News18 English

New Drug May Offer Hope to Alzheimer's Patients

Advancing the fight against Alzheimer's disease, Japanese researchers have in a breakthrough study, developed a new drug that could help treat the most common form of dementia.

IANS

Updated:January 27, 2017, 1:34 PM IST
facebookTwittergoogleskypewhatsapp
New Drug May Offer Hope to Alzheimer's Patients
Image for representational purpose only (AFP PHOTO / SEBASTIEN BOZON)
Loading...
Advancing the fight against Alzheimer's disease, Japanese researchers have in a breakthrough study, developed a new drug that could help treat the most common form of dementia.

Alzheimer's is a progressive disease that destroys memory and other important mental functions.

The study, led by researchers at Tohoku University in Japan and published in the journal Neuropharmacology -- showed that the new drug -- SAK3 -- stimulates the release of acetylcholine in the brain and improves cognition by activating the memory.

Acetylcholine is a neurotransmitter in the brain that plays an important role in controlling attention and cognition.

A dysfunction in the acetylcholine system is believed to be one of the causes of Alzheimer's disease (AD) and vascular dementia.

SAK3 also halted the production of amyloid beta protein -- the main component of the amyloid plaques found in the brains of Alzheimer patients.

SAK3 reduces the production of amyloid beta protein, which could lead to the development of the first disease-modifying drug to prevent mild to severe Alzheimer disease, said Kohji Fukunaga, professor at Tohoku University.

For the study, the team conducted experiments on mice model which have so far proven to be safe and well tolerated.

The drug SAK3 is now in the preclinical stage of drug development and clinical trials are expected to begin in the next few years, the researchers said.

| Edited by: Gurleen Nagpal
Read full article
Loading...
Next Story
Next Story

Also Watch

facebookTwittergoogleskypewhatsapp
 
 

Live TV

Loading...
Countdown To Elections Results
  • 01 d
  • 12 h
  • 38 m
  • 09 s
To Assembly Elections 2018 Results